HYPR
Price:
$1.6
Market Cap:
$134.74M
Headquartered in Guilford, Connecticut, Hyperfine, Inc. commenced operations in 2014. The firm develops and supplies imaging, monitoring, and magnetic resonance imaging (MRI) technologies. A key offering is its Swoop Portable MR imaging system, which utilizes integrated hardware and software services to meet a vital requirement for point-of-care medical diagnostics.
Industry
Medical - Devices
IPO Date
2021-01-28
Stock Exchange
NASDAQ
Ticker
HYPR
According to Hyperfine, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.00. This represents a change of 45.63% compared to the average of -2.75 of the last 4 quarters.
The mean historical PE Ratio of Hyperfine, Inc. over the last ten years is -3.94. The current -4.00 PE Ratio has changed 10.06% with respect to the historical average. Over the past ten years (40 quarters), HYPR's PE Ratio was at its highest in in the September 2022 quarter at -1.13. The PE Ratio was at its lowest in in the December 2020 quarter at -25.54.
Average
-3.94
Median
-2.28
Minimum
-10.76
Maximum
-0.81
Discovering the peaks and valleys of Hyperfine, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 336.56%
Maximum Annual PE Ratio = -0.81
Minimum Annual Increase = -89.75%
Minimum Annual PE Ratio = -10.76
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -2.28 | 44.93% |
| 2024 | -1.57 | -13.01% |
| 2023 | -1.81 | 123.66% |
| 2022 | -0.81 | -89.75% |
| 2021 | -7.88 | -26.79% |
| 2020 | -10.76 | 336.56% |
The current PE Ratio of Hyperfine, Inc. (HYPR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.89
5-year avg
-2.87
10-year avg
-3.94
Hyperfine, Inc.’s PE Ratio is less than InspireMD, Inc. (-1.25), less than Vivani Medical, Inc. (-2.88), less than AVITA Medical, Inc. (-0.03), less than FONAR Corporation (18.90), greater than Edap Tms S.a. (-5.87), less than Pulmonx Corporation (-0.98), less than Connect Biopharma Holdings Limited (-4.00), less than Quince Therapeutics, Inc. (-0.15), greater than Quipt Home Medical Corp. (-14.44), less than ImageneBio Inc (-1.29),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.25 | $33.26M | |
| -2.88 | $67.94M | |
| -0.03 | $99.62M | |
| 18.90 | $117.76M | |
| -5.87 | $178.23M | |
| -0.98 | $54.06M | |
| -4.00 | $125.93M | |
| -0.15 | $5.26M | |
| -14.44 | $162.30M | |
| -1.29 | $67.67M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hyperfine, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hyperfine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hyperfine, Inc.'s PE Ratio?
How is the PE Ratio calculated for Hyperfine, Inc. (HYPR)?
What is the highest PE Ratio for Hyperfine, Inc. (HYPR)?
What is the 3-year average PE Ratio for Hyperfine, Inc. (HYPR)?
What is the 5-year average PE Ratio for Hyperfine, Inc. (HYPR)?
How does the current PE Ratio for Hyperfine, Inc. (HYPR) compare to its historical average?